The Canadian-based cannabis operator, Curaleaf Holdings, Inc., announced today that its shares have resumed trading on the OTC market under its original stock symbol "CURLF," marking the formal conclusion of a temporary transition period that was established due to corporate restructuring.
The company finalized a reorganization of its corporate structure in May 2026, consolidating all its operating subsidiaries into a single holding company framework. This move was designed to streamline operations and enhance capital allocation efficiency. During this restructuring process, a temporary trading symbol was utilized to accommodate related legal and regulatory procedures. With all integration work now successfully completed, the company has officially reinstated its long-standing CURLF ticker.
The Chief Executive Officer of Curaleaf stated that the reinstatement of the CURLF symbol signifies the successful completion of the company's restructuring transition phase. The new corporate structure is expected to aid in more efficiently executing the company's growth strategy and improve the consistency of financial reporting. The CEO expressed gratitude to investors and shareholders for their understanding and support during this period.
Curaleaf is one of the largest vertically integrated cannabis operators in the United States, with operations spanning medical and adult-use cannabis markets in approximately 20 states. The company runs over 150 retail dispensaries alongside dozens of cultivation and processing facilities. It has achieved rapid expansion in recent years through sustained mergers and acquisitions, reporting annual revenue of around $1.5 billion for 2025 and holding leading positions in several core markets.
While the cannabis industry continues to face challenges in capital access due to federal legal restrictions, the ongoing legalization efforts in numerous U.S. states present a broad growth outlook. Curaleaf recently reported positive first-quarter results, with revenue increasing by 12% year-over-year, primarily driven by robust demand in key markets such as New York, New Jersey, and Florida.
The company indicated it remains focused on optimizing operational efficiency and expanding its retail network in high-potential markets. Curaleaf plans to open approximately 15 new dispensaries in the second half of 2026 and is advancing collaborations with medical cannabis programs in multiple states. With the ticker reinstatement and corporate restructuring now complete, the company is scheduled to release its second-quarter financial results in early August. At that time, it will provide investors with updates on the progress of the post-restructuring business integration and the latest developments in its strategic execution.
Comments